Back

Influence of the non-lipoprotein(a) apolipoprotein B/lipoprotein(a) ratio and other risk factors on coronary arterial aterosclerotic burden in acute coronary syndrome.

30 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (3) Scores ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Antonio Meseguer Hernandez

General University Hospital Santa Lucia, Cartagena (Spain)

5 More presentations in this session

Presentation thumbnail
High-sensitive CRP is a reliable biomarker for predicting events in a cardiovascular population
Doctor G. Bettencourt Abreu (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) measurements identify patients with elevated likelihood of obstructive coronary artery disease despite very low or low clinical likelihood
Doctor G. Brix (Herning, DK)
Abstract Slides Video
Presentation thumbnail
Age and risk scores for detecting coronary artery calcification in heterozygous familial hypercholesterolemia
Mr O. Decanini Cantarella Silva (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Risk of cardiovascular events in U.S. patients using the SMART risk score
Doctor D. Fernandez Vazquez (Lorca, ES)
Abstract Slides Video
Presentation thumbnail
A 4-protein biomarker risk score enhances cardiovascular risk assessment: insights from the multi-ethnic study of atherosclerosis
Assistant Professor J. Medina-Inojosa (Atlanta, US)
Abstract Slides

Access the full session

Session thumbnail
Risk factors (3)

The Event

Event poster

ESC Congress 2025

30 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of lipoprotein(a) with severity of coronary artery atherosclerosis in patients with acute coronary syndromes
thumbnail
Congress Presentation
The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease
thumbnail
Congress Presentation
Lipoprotein A and cardiovascular risk in acute myocardial infarction: what have we learned in 5 years?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources